Flozins in time: SGLT2 inhibitors from discovery to standard of care
AstraZeneca |
Monday
13:30 – 13:35 Chair welcome and introductions 13:35 – 13:45 A brief history of flozins 13:45 – 14:40 Into the clinic: Current practices in T2D care 14:40 – 14:55 Panel discussion 14:55 – 15:00 Summary and close 2 October 2023 13:30 – 15:00 CEST Seoul Hall
iCan, a new commercial stage, innovative glucose sensor.
Sinocare Meditech Inc. |
Monday
Our science to date including USA and Chinese clinical experience. 2 October 2023 13:00 – 14:00 CEST Vienna Hall
Should Faster Rapid-Acting Insulins be the standard for first line therapy?
Eli Lilly and Company |
Monday
Coming soon… 2 October 2023 17:00 – 18:00 CEST Warsaw Hall
Triple Action in Type 2 Diabetes Management: Canagliflozin in Focus
Menarini Group |
Tuesday
Chair: Stefano Del Prato (ITA) 18:30 – 18:32 General introduction: from active to proactive diabetes management Stefano Del Prato (ITA) 18:32 – 18:39 Prioritize early glycaemic control John Wilding (UK) 18:39 – 18:46 Kidney Protection: CREDENCE study under the magnifying glass David Wheeler (UK) 18:46 – 18:53 Do not forget the heart: Diabetes and Cardiovascular […]
Ertugliflozin in the Holistic-Person Centered Approach to T2DM Management
MSD |
Tuesday
18:30 – 18:35 Opening Remarks 18:35 – 18:45 Ertugliflozin & Glycemic Management in the Holistic-Person Centered Approach to T2DM Management Sam Dagogo-Jack (USA) 18:45 – 18:55 Ertugliflozin & Weight Management in the Holistic-Person Centered Approach to T2DM Management 18:55 – 19:05 Ertugliflozin & Cardiovascular Risk Factor and Cardiorenal Protection Management in the Holistic-Person Centered Approach to T2DM […]
Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH
Madrigal Pharmaceuticals |
Monday
Chair: Michael Roden (GER) 13:30 – 13:35 Introduction Michael Roden (GER) 13:35 – 13:50 NASH: a growing unmet therapeutic need Jörn Schattenberg (GER) 13:50 – 14:05 The underestimated role of thyroid hormone pathway in the pathophysiology of NASH Eveline Bruinstroop (NLD) 14:05 – 14:20 Discussion and Q&As Michael Roden (GER)Jörn Schattenberg (GER)Eveline Bruinstroop (NLD) 14:20 – […]
Coming soon…
Medtronic International Trading Sàrl |
Tuesday
Coming soon… 3 October 2023 07:45 – 08:45 CEST Seoul Hall
Translating data into insights for tailored value-based care
Roche Diabetes Care GmbH |
Monday
Chairs: Partha Kar (UK), Bernhard Kulzer (GER) 16:00 – 16:05 Introduction Partha Kar (UK)Bernhard Kulzer (GER) 16:05 – 16:30 How effective is a digital logbook in reducing individual levels of diabetes distress? – Results from the mySugr PRO study Dominic Ehrmann (GER) 16:30 – 16:55 How can connected digital solutions support optimal care provision? – […]
Coming soon…
Tandem Diabetes Care |
Wednesday
Coming soon… 4 October 2023 18:45 – 19:45 CEST Sofia Hall
Enhancing Quality of Life through Glycemic Control: A patient centric approach
Servier Affaires Medicales |
Wednesday
Chair: Kamlesh Khunti (UK) 18:45 – 18:50 Introduction Kamlesh Khunti (UK) 18:50 – 19:05 Glycemic control today, an overview of the state of the art Kamlesh Khunti (UK) 19:05 – 19:20 Glycemic control, the cornerstone of the quality of life of people living with type 2 diabetes Juliana Chan (HKG) 19:20 – 19:35 Impact of […]
